MARKET

MEIP

MEIP

MEI Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.340
-0.010
-0.43%
Opening 13:42 01/24 EST
OPEN
2.350
PREV CLOSE
2.350
HIGH
2.400
LOW
2.280
VOLUME
193.04K
TURNOVER
--
52 WEEK HIGH
3.410
52 WEEK LOW
1.440
MARKET CAP
238.17M
P/E (TTM)
-32.2314
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MEIP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MEIP News

  • MEI Pharma: Best-In-Class P13K Delta Inhibitor Makes Significant Progress In The Clinic
  • Seeking Alpha - Article.01/02 16:15
  • MEI Pharma (MEIP) Catches Eye: Stock Jumps 8.1%
  • Zacks.12/31/2019 13:58
  • 15 Stocks Moving in Tuesday's Pre-Market Session
  • Benzinga.12/31/2019 12:32
  • Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus
  • Benzinga.12/29/2019 23:38

More

Industry

Biotechnology & Medical Research
-2.20%
Pharmaceuticals & Medical Research
-1.65%

Hot Stocks

Name
Price
%Change

About MEIP

MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of drugs and therapies for treatment of cancer. The Company's portfolio of clinical drug candidates includes Pracinostat, ME-344 and ME-401. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor indicated for the treatment of hematologic diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). ME-344 is an isoflavone-based mitochondrial inhibitor targeting a mitochondrial component of the terminal respiratory chain complex in rapidly proliferating cells. ME-401 is an oral inhibitor of phosphatidylinositide 3-kinase (PI3K) delta, a molecular target that plays a critical role in the proliferation and survival of hematologic cancer cells. Pracinostat has been tested in multiple Phase I and Phase II clinical trials in advanced hematologic malignancies and solid tumor indications.
More

Webull offers MEI Pharma Inc (MEIP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.